Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study
Abstract Background Meropenem-vaborbactam is a recent and promising option for the treatment of KPC-producing Klebsiella pneumoniae (KPC-Kp) infections, including those resistant to ceftazidime-avibactam. Methods We conducted a retrospective analysis of observational data from 19 Italian hospitals o...
Spremljeno u:
Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Jezik: | engleski |
Izdano: |
2024
|
Online pristup: | https://doi.org/10.1093/ofid/ofae273 https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofae273/57451797/ofae273.pdf |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|